| Sherif A Soliman, MD | |
|
1340 Belmont Ave, Suite 2300, Youngstown, OH 44504-1125 | |
| (330) 746-1488 | |
| (330) 746-5611 |
| Full Name | Sherif A Soliman |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 35 Years |
| Location | 1340 Belmont Ave, Youngstown, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174594915 | NPI | - | NPPES |
| 0915830 | Medicaid | PA | |
| 2268353 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 350722755 (Ohio) | Primary |
| 207RN0300X | Internal Medicine - Nephrology | MD417950 (Pennsylvania) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc - Youngstown | Youngstown, OH | Dialysis facility |
| St Elizabeth Youngstown Hospital | Youngstown, OH | Hospital |
| Mh St Joseph Warren Hospital | Warren, OH | Hospital |
| Hmhp St Elizabeth Boardman Health Center | Boardman, OH | Hospital |
| Sharon Regional Health System | Sharon, PA | Hospital |
| Upmc Jameson | New castle, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Kidney Group Inc | 0941291231 | 19 |
| The Kidney Group Inc | 0941291231 | 19 |
News Archive
Purchasers of pharmaceutical drugs including consumers and health plans will soon enjoy a rollback of benchmark prices of some of the most common prescription medications after a Federal Appeals Court last week affirmed the approval of a settlement with two leading drug-pricing publishers, First DataBank, Inc. and Medi-Span, a division of Wolters Kluwer Health, Inc.
The current surge in coronavirus disease 2019 (COVID-19) cases poses challenges for providers and institutions in delivering care to infected patients while also placing demands on them to keep up with timely and sometimes critical care for patients with cancer, heart disease and other serious illnesses who might experience advanced complications and/or earlier death if they have lapses in their care.
A novel therapy designed to help stimulate the body's immune system response against cancer appears to be safe to use as alone or in combination with immune checkpoint inhibitors.
Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.
› Verified 4 days ago
| Entity Name | The Kidney Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982741971 PECOS PAC ID: 0941291231 Enrollment ID: O20040524001423 |
News Archive
Purchasers of pharmaceutical drugs including consumers and health plans will soon enjoy a rollback of benchmark prices of some of the most common prescription medications after a Federal Appeals Court last week affirmed the approval of a settlement with two leading drug-pricing publishers, First DataBank, Inc. and Medi-Span, a division of Wolters Kluwer Health, Inc.
The current surge in coronavirus disease 2019 (COVID-19) cases poses challenges for providers and institutions in delivering care to infected patients while also placing demands on them to keep up with timely and sometimes critical care for patients with cancer, heart disease and other serious illnesses who might experience advanced complications and/or earlier death if they have lapses in their care.
A novel therapy designed to help stimulate the body's immune system response against cancer appears to be safe to use as alone or in combination with immune checkpoint inhibitors.
Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.
› Verified 4 days ago
| Entity Name | Center For Vascular Access Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720287923 PECOS PAC ID: 6305937061 Enrollment ID: O20070809000396 |
News Archive
Purchasers of pharmaceutical drugs including consumers and health plans will soon enjoy a rollback of benchmark prices of some of the most common prescription medications after a Federal Appeals Court last week affirmed the approval of a settlement with two leading drug-pricing publishers, First DataBank, Inc. and Medi-Span, a division of Wolters Kluwer Health, Inc.
The current surge in coronavirus disease 2019 (COVID-19) cases poses challenges for providers and institutions in delivering care to infected patients while also placing demands on them to keep up with timely and sometimes critical care for patients with cancer, heart disease and other serious illnesses who might experience advanced complications and/or earlier death if they have lapses in their care.
A novel therapy designed to help stimulate the body's immune system response against cancer appears to be safe to use as alone or in combination with immune checkpoint inhibitors.
Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.
› Verified 4 days ago
| Entity Name | Dialysis Access Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1801457478 PECOS PAC ID: 6204252646 Enrollment ID: O20200817002411 |
News Archive
Purchasers of pharmaceutical drugs including consumers and health plans will soon enjoy a rollback of benchmark prices of some of the most common prescription medications after a Federal Appeals Court last week affirmed the approval of a settlement with two leading drug-pricing publishers, First DataBank, Inc. and Medi-Span, a division of Wolters Kluwer Health, Inc.
The current surge in coronavirus disease 2019 (COVID-19) cases poses challenges for providers and institutions in delivering care to infected patients while also placing demands on them to keep up with timely and sometimes critical care for patients with cancer, heart disease and other serious illnesses who might experience advanced complications and/or earlier death if they have lapses in their care.
A novel therapy designed to help stimulate the body's immune system response against cancer appears to be safe to use as alone or in combination with immune checkpoint inhibitors.
Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sherif A Soliman, MD 1340 Belmont Ave, Suite 2300, Youngstown, OH 44504-1125 Ph: (330) 746-1488 | Sherif A Soliman, MD 1340 Belmont Ave, Suite 2300, Youngstown, OH 44504-1125 Ph: (330) 746-1488 |
News Archive
Purchasers of pharmaceutical drugs including consumers and health plans will soon enjoy a rollback of benchmark prices of some of the most common prescription medications after a Federal Appeals Court last week affirmed the approval of a settlement with two leading drug-pricing publishers, First DataBank, Inc. and Medi-Span, a division of Wolters Kluwer Health, Inc.
The current surge in coronavirus disease 2019 (COVID-19) cases poses challenges for providers and institutions in delivering care to infected patients while also placing demands on them to keep up with timely and sometimes critical care for patients with cancer, heart disease and other serious illnesses who might experience advanced complications and/or earlier death if they have lapses in their care.
A novel therapy designed to help stimulate the body's immune system response against cancer appears to be safe to use as alone or in combination with immune checkpoint inhibitors.
Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.
› Verified 4 days ago
Dr. Khaled Al-taieb, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 465 Gypsy Ln Apt 407, Youngstown, OH 44504 Phone: 330-391-0462 | |
Dr. Michael Allen Van Winkle, D.O Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-3676 Fax: 330-480-7979 | |
Dr. Ayesha Khadka, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: St. Elizabeth Youngstown Hospital, Internal Medicine, 1001 Covington St. Youngstown, Youngstown, OH 44510 Phone: 330-480-2616 | |
Dr. Ghazaleh Bigdeli, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 925 Trailwood Dr, Youngstown, OH 44512 Phone: 330-758-7575 | |
Dr. Jeffrey C Halley, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 250 Debartolo Pl, Suite 2750, Youngstown, OH 44512 Phone: 330-758-7703 Fax: 330-758-4930 | |
Dr. Masud R Bhatti, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 835 Southwestern Run, Youngstown, OH 44514 Phone: 330-318-1100 | |
Chakri Yarlagadda, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1001 Belmont Ave, Youngstown, OH 44504 Phone: 330-747-6446 Fax: 330-747-6843 |